Marshall Wace’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.72M | Buy |
626,581
+58,582
| +10% | +$441K | 0.01% | 1068 |
|
|
2025
Q1 | $4.3M | Sell |
567,999
-83,694
| -13% | -$634K | 0.01% | 1059 |
|
|
2024
Q4 | $7.94M | Sell |
651,693
-402,071
| -38% | -$4.9M | 0.01% | 812 |
|
|
2024
Q3 | $17.6M | Sell |
1,053,764
-130,273
| -11% | -$2.18M | 0.02% | 498 |
|
|
2024
Q2 | $20.6M | Buy |
1,184,037
+1,136,993
| +2,417% | +$19.8M | 0.03% | 442 |
|
|
2024
Q1 | $802K | Buy |
47,044
+13,670
| +41% | +$233K | ﹤0.01% | 1523 |
|
|
2023
Q4 | $340K | Buy |
+33,374
| New | +$340K | ﹤0.01% | 1553 |
|
|
2023
Q3 | – | Sell |
-10,837
| Closed | -$117K | – | 1898 |
|
|
2023
Q2 | $117K | Buy |
+10,837
| New | +$117K | ﹤0.01% | 1869 |
|
|
2022
Q4 | – | Sell |
-40,576
| Closed | -$520K | – | 2371 |
|
|
2022
Q3 | $520K | Sell |
40,576
-2,547
| -6% | -$32.6K | ﹤0.01% | 2025 |
|
|
2022
Q2 | $553K | Buy |
+43,123
| New | +$553K | ﹤0.01% | 2108 |
|
|
2021
Q3 | – | Sell |
-74,951
| Closed | -$1.93M | – | 2442 |
|
|
2021
Q2 | $1.93M | Buy |
+74,951
| New | +$1.93M | 0.01% | 1158 |
|